HUT64296A - Method for producing 1,4-bis (amino-hydroxi-alkyl-amino)-anthraquinone and medical preparatives containing them - Google Patents

Method for producing 1,4-bis (amino-hydroxi-alkyl-amino)-anthraquinone and medical preparatives containing them

Info

Publication number
HUT64296A
HUT64296A HU9202207A HU220792A HUT64296A HU T64296 A HUT64296 A HU T64296A HU 9202207 A HU9202207 A HU 9202207A HU 220792 A HU220792 A HU 220792A HU T64296 A HUT64296 A HU T64296A
Authority
HU
Hungary
Prior art keywords
amino
hydroxi
anthraquinone
bis
alkyl
Prior art date
Application number
HU9202207A
Other languages
English (en)
Other versions
HU9202207D0 (en
Inventor
Jack B Jiang
Mary George Johnson
Original Assignee
Sphinx Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphinx Pharma Corp filed Critical Sphinx Pharma Corp
Publication of HU9202207D0 publication Critical patent/HU9202207D0/hu
Publication of HUT64296A publication Critical patent/HUT64296A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones
    • C07C225/36—Amino anthraquinones the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9202207A 1990-11-02 1991-10-30 Method for producing 1,4-bis (amino-hydroxi-alkyl-amino)-anthraquinone and medical preparatives containing them HUT64296A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60824890A 1990-11-02 1990-11-02
US07/609,416 US5141957A (en) 1990-11-02 1990-11-05 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c

Publications (2)

Publication Number Publication Date
HU9202207D0 HU9202207D0 (en) 1992-12-28
HUT64296A true HUT64296A (en) 1993-12-28

Family

ID=27085707

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9202207A HUT64296A (en) 1990-11-02 1991-10-30 Method for producing 1,4-bis (amino-hydroxi-alkyl-amino)-anthraquinone and medical preparatives containing them

Country Status (11)

Country Link
US (1) US5141957A (hu)
EP (1) EP0509088A4 (hu)
JP (1) JPH05505829A (hu)
KR (1) KR920703512A (hu)
AU (1) AU641581B2 (hu)
BR (1) BR9106117A (hu)
CA (1) CA2072884A1 (hu)
FI (1) FI923031A0 (hu)
HU (1) HUT64296A (hu)
NO (1) NO922601D0 (hu)
WO (1) WO1992007558A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA936396B (en) * 1992-09-08 1994-06-13 Univ Vermont 4-Substituted 6,9-bis(substituted-amino)benzo[g] isoquinoline-5,10,diones
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
WO1995034307A1 (en) * 1994-06-14 1995-12-21 Sloan-Kettering Institute For Cancer Research Ceramide-activated protein kinase and methods of use of effectors
US6232299B1 (en) 1996-05-01 2001-05-15 Eli Lilly And Company Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
US6376467B1 (en) * 1998-10-09 2002-04-23 The Regents Of The University Of California Use of inhibitors of protein kinase C epsilon to treat pain
US6717030B2 (en) * 1998-07-06 2004-04-06 The Regents Of The University Of California Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
CA2336709A1 (en) * 1998-07-06 2000-01-13 Robert O. Messing Use of inhibitors of protein kinase c epsilon to treat pain
EP1572115B1 (en) * 2002-11-27 2015-01-21 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
US20040175384A1 (en) * 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
EP2228069A1 (en) 2003-09-16 2010-09-15 Garvan Institute Of Medical Research Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith.
US8592368B2 (en) 2003-12-19 2013-11-26 University Of South Florida JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
WO2006108270A1 (en) * 2005-04-11 2006-10-19 Pharmagap Inc. Inhibitors of protein kinases and uses thereof
WO2007033374A2 (en) 2005-09-16 2007-03-22 Schering Corporation Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
JP2010516709A (ja) * 2007-01-19 2010-05-20 カイ ファーマシューティカルズ インコーポレーティッド 疼痛減弱のためのイプシロン阻害化合物の使用方法
US20120208750A1 (en) 2009-09-29 2012-08-16 Joslin Diabetes Center, Inc. Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
US9980936B2 (en) 2014-05-05 2018-05-29 Emory University BH4 antagonists and methods related thereto

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1540733A (en) * 1923-10-25 1925-06-02 British Dyestuffs Corp Ltd Dyestuffs of the anthraquinone series
US2411148A (en) * 1943-10-23 1946-11-19 Eastman Kodak Co Anthraquinone dyestuffs
US3960751A (en) * 1973-09-19 1976-06-01 Matsushita Electric Industrial Co., Ltd. Electro-optical display element
US4197249A (en) * 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4310666A (en) * 1978-04-10 1982-01-12 United States Of America Anti-neoplastic 1,4-bis-(substituted aminoalkyl amino)-anthraquinones
US4526989A (en) * 1978-07-11 1985-07-02 American Cyanamid Company 1,4-Bis (substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
EP0079862B1 (de) * 1981-11-18 1986-01-15 Ciba-Geigy Ag 1,4-Diaminoanthrachinonverbindungen
US4540788A (en) * 1983-07-14 1985-09-10 American Cyanamid Company Schiff bases of [(aminoalkyl or substituted aminoalkyl)amino]-9,10-anthracenediones
DE3331296A1 (de) * 1983-08-31 1985-03-14 Hoechst Ag, 6230 Frankfurt Mono- und bisfunktionelle anthrachinon-(oxy-2,3-oxidopropane), verfahren zu ihrer herstellung und ihre verwendung
US4894451A (en) * 1985-04-01 1990-01-16 The University Of Vermont Unsymmetrical 1,4-bis(aminoalkylamino)-anthracene-9, 10-diones and derivatives
JPS6315853A (ja) * 1986-07-07 1988-01-22 Dainippon Printing Co Ltd 熱転写シ−ト用染料
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
JPH0219818A (ja) * 1988-07-07 1990-01-23 Nec Corp 暗視双眼鏡
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
GB8923075D0 (en) * 1989-10-13 1989-11-29 Patterson Laurence H Anti-cancer compounds
HUT64295A (en) * 1990-11-02 1993-12-28 Sphinx Pharma Corp Method for producing bis-(hydroxy-alkyl-amino)-anthraquinone derivatives as well as pharmaceutical preparatives containing them

Also Published As

Publication number Publication date
FI923031A (fi) 1992-06-30
KR920703512A (ko) 1992-12-18
EP0509088A1 (en) 1992-10-21
CA2072884A1 (en) 1992-05-03
HU9202207D0 (en) 1992-12-28
AU641581B2 (en) 1993-09-23
NO922601L (no) 1992-07-01
AU9086291A (en) 1992-05-26
JPH05505829A (ja) 1993-08-26
US5141957A (en) 1992-08-25
WO1992007558A1 (en) 1992-05-14
EP0509088A4 (en) 1993-03-24
NO922601D0 (no) 1992-07-01
FI923031A0 (fi) 1992-06-30
BR9106117A (pt) 1993-03-09

Similar Documents

Publication Publication Date Title
EP0409427A3 (en) Catheter apparatus, and compositions useful for producing same
HUT53362A (en) Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same
PL295811A2 (en) Method of obtaining 1,2-dihydro-2-ketopyridines
HUT64296A (en) Method for producing 1,4-bis (amino-hydroxi-alkyl-amino)-anthraquinone and medical preparatives containing them
HU9203847D0 (en) Method for producing hydroxi-piperidines alkoxi ones
HUT58747A (en) Process for producing /6,7-substituted -8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolin-carboxylic acid-0 upper 3, 0 upper 4-bis/acyl-oxy-o-borate and salts
HU913960D0 (en) Method for producing benzodiazepinones and medical preparatives containing said compounds
HUT57724A (en) Process for producing dialkyl-(2,3-pyridinedicarboxylate) and its derivatives
IL91258A0 (en) 1,3,5-trinitro-2,4,6-tripicryl-benzene and method for producing it
EP0252391A3 (en) 1,2,2-trimethyl-1-phenyl polydisilane and method for producing the same
DE3760508D1 (en) 1,1-dichloro-1,2,2-trimethyl-2-phenyldisilane and method for producing the same
HU9203539D0 (en) Substituted 1,5-pentane-dioles and method for producing them
IL88583A (en) Method for producing 4,4'-dibromobiphenyl
EP0474016A3 (en) Method for the preparation of 2,3-dihydro-benzofuranes
HU9203326D0 (en) Method for producing 1,5-benzo-thiazepinone derivatives and pharmaceutical preparatives containing them
HU9201457D0 (en) New aryl-amino-carbonyl compounds and method for producing them
HU9203092D0 (en) Method for producing n-benzoxa-diazolo-pyranyl-lactames and pharmaceutical preparatives containing them
EP0438715A3 (en) 1,1-bicyclo-substituted fluorinated cyclopentanes and method for their production
CS390590A3 (en) Substituted 5,15-diphenylporphyrins and process for preparing thereof
PL286447A1 (en) Method of obtaining 1,3-dimethyl-4-/-hydroxyaminopropane/-uracil
EP0432782A3 (en) Process for preparing 4,4'-dihydroxybiphenyl
CS143387A1 (en) 2,6-dimethylphenylcarbamoylmethylpyridiniumchloride and process for preparing thereof
RO102524B1 (en) 3,5 di-tert-butyl-hydroxy-benzyl alcohol producing method
HU913877D0 (en) Method for producing n-aryl-3-aryl-4-substituted-2,3,4,5-tetrahydro-1b-pyrazol-1-carboxamides
HU206496B (en) Process for producing 2,3-dichloro-6-nitro-benzonitril

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee